Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Well differentiated arginase-1 negative hepatocellular carcinoma.

Obiorah IE, Chahine J, Park BU, Ko K, deGuzman J, Kallakury B.

Transl Gastroenterol Hepatol. 2019 Sep 3;4:66. doi: 10.21037/tgh.2019.08.01. eCollection 2019.

2.

Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors.

Sharma P, Alsharif S, Bursch K, Parvathaneni S, Anastasakis DG, Chahine J, Fallatah A, Nicolas K, Sharma S, Hafner M, Kallakury B, Chung BM.

Sci Rep. 2019 Oct 10;9(1):14650. doi: 10.1038/s41598-019-51195-9.

3.

Cholecystokinin Receptor Antagonist Therapy Decreases Inflammation and Fibrosis in Chronic Pancreatitis.

Nadella S, Ciofoaia V, Cao H, Kallakury B, Tucker RD, Smith JP.

Dig Dis Sci. 2019 Oct 9. doi: 10.1007/s10620-019-05863-5. [Epub ahead of print]

PMID:
31598921
4.

Liver-Targeted Toll-Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus.

Korolowizc KE, Li B, Huang X, Yon C, Rodrigo E, Corpuz M, Plouffe DM, Kallakury BV, Suresh M, Wu TY, Miller AT, Menne S.

Hepatol Commun. 2019 Jul 8;3(10):1296-1310. doi: 10.1002/hep4.1397. eCollection 2019 Oct.

5.

African-American Prostate Normal and Cancer Cells for Health Disparities Research.

Nicolas N, Upadhyay G, Velena A, Kallakury B, Rhim JS, Dritschilo A, Jung M.

Adv Exp Med Biol. 2019;1164:101-108. doi: 10.1007/978-3-030-22254-3_8.

PMID:
31576543
6.

Short and long-term effects of CDK4/6 inhibition on early stage breast cancer.

Kietzman WB, Graham GT, Ory V, Sharif G, Kushner MH, Gallanis GT, Kallakury B, Wellstein A, Riegel AT.

Mol Cancer Ther. 2019 Aug 26. pii: molcanther.0231.2019. doi: 10.1158/1535-7163.MCT-19-0231. [Epub ahead of print]

PMID:
31451564
7.

Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer.

Saenz FR, Ory V, Schmidt MO, Kallakury BV, Mueller SC, Furth PA, Wellstein A, Riegel AT.

Neoplasia. 2019 Aug 19;21(10):963-973. doi: 10.1016/j.neo.2019.07.001. [Epub ahead of print]

8.

p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.

Aggarwal M, Saxena R, Asif N, Sinclair E, Tan J, Cruz I, Berry D, Kallakury B, Pham Q, Wang TTY, Chung FL.

J Exp Clin Cancer Res. 2019 Jul 15;38(1):307. doi: 10.1186/s13046-019-1267-z.

9.

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.

Tucker RD, Ciofoaia V, Nadella S, Gay MD, Cao H, Huber M, Safronenka A, Shivapurkar N, Kallakury B, Kruger AJ, Kroemer AHK, Smith JP.

Dig Dis Sci. 2019 Jul 11. doi: 10.1007/s10620-019-05722-3. [Epub ahead of print]

PMID:
31297627
10.

Fractionated and Acute Proton Radiation Show Differential Intestinal Tumorigenesis and DNA Damage and Repair Pathway Response in ApcMin/+ Mice.

Suman S, Kallakury BVS, Fornace AJ Jr, Datta K.

Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):525-536. doi: 10.1016/j.ijrobp.2019.06.2532. Epub 2019 Jul 2.

PMID:
31271826
11.

Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis.

Nadella S, Burks J, Huber M, Wang J, Cao H, Kallakury B, Tucker RD, Boca SM, Jermusyck A, Collins I, Vietsch EE, Pierobon M, Hodge KA, Cui W, Amundadottir LT, Petricoin E 3rd, Shivapurkar N, Smith JP.

Pancreas. 2019 Aug;48(7):894-903. doi: 10.1097/MPA.0000000000001360.

PMID:
31268978
12.

Bridging Hepatocellular Carcinoma to Transplant: Transarterial Chemoembolization Response, Tumor Biology, and Recurrence after Transplantation in a 12-Year Transplant Cohort.

Sandow T, Pavlus J, Field D, Lacayo E, Cohen E, Lynskey G, Caridi T, Buckley D, Cardella J, Kallakury B, Spies J, Kim AY.

J Vasc Interv Radiol. 2019 Jul;30(7):995-1003. doi: 10.1016/j.jvir.2018.12.736. Epub 2019 May 17.

PMID:
31109853
13.

Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival.

Obiorah IE, Chahine J, Ko K, Park BU, deGuzman J, Kallakury B.

Gastroenterology Res. 2019 Apr;12(2):78-87. doi: 10.14740/gr1156. Epub 2019 Apr 7.

14.

Parental obesity programs pancreatic cancer development in offspring.

da Cruz RS, Clarke J, Curi AC, Al-Yawar A, Jin L, Baird A, Cruz I, Kallakury BV, de Assis S.

Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0016.R1. doi: 10.1530/ERC-19-0016. [Epub ahead of print]

PMID:
30865925
15.

IgG4-Related Appendiceal Disease: A First Case Report Fulfilling All Pathological Diagnostic Criteria and With Concomitant S100-Positive Dendritic/Schwann Cell Hyperplasia.

Kwon DH, Kallakury B, DeBrito P, Azumi N.

Int J Surg Pathol. 2019 Aug;27(5):541-546. doi: 10.1177/1066896919830213. Epub 2019 Feb 17.

PMID:
30773953
16.

Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death.

Hsu WH, Zhao X, Zhu J, Kim IK, Rao G, McCutcheon J, Hsu ST, Teicher B, Kallakury B, Dowlati A, Zhang YW, Giaccone G.

J Thorac Oncol. 2019 Jun;14(6):1032-1045. doi: 10.1016/j.jtho.2019.01.028. Epub 2019 Feb 14. Erratum in: J Thorac Oncol. 2019 Aug;14(8):1484.

PMID:
30771522
17.

Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment.

Zhao X, Kallakury B, Chahine JJ, Hartmann D, Zhang Y, Chen Y, Zhang H, Zhang B, Wang C, Giaccone G.

J Thorac Oncol. 2019 May;14(5):914-923. doi: 10.1016/j.jtho.2019.01.019. Epub 2019 Feb 5.

PMID:
30735815
18.

Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non-Small Cell Lung Cancer Cells.

Day TF, Kallakury BVS, Ross JS, Voronel O, Vaidya S, Sheehan CE, Kasid UN.

Mol Cancer Res. 2019 May;17(5):1207-1219. doi: 10.1158/1541-7786.MCR-18-0731. Epub 2019 Jan 15.

PMID:
30647104
19.

Differential efatutazone's impact on mammary neoplasia dependent upon Brca1 dose.

Alothman SJ, Wang W, Chao S, Kallakury BV, Díaz-Cruz ES, Furth PA.

Endocr Relat Cancer. 2018 Dec 1;25(12):L53-L57. doi: 10.1530/ERC-18-0299. No abstract available.

PMID:
30400020
20.

Concurrent Diagnosis of Chronic Myeloid Leukemia and Follicular Lymphoma: An Unreported Presentation.

Starr AG, Jonna SR, Chahine JJ, Kallakury BV, Ujjani CS.

Case Rep Hematol. 2018 Sep 9;2018:7493601. doi: 10.1155/2018/7493601. eCollection 2018.

21.

Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC.

Hinzman CP, Aljehane L, Brown-Clay JD, Kallakury B, Sonahara F, Goel A, Trevino J, Banerjee PP.

Carcinogenesis. 2018 Dec 31;39(12):1548-1559. doi: 10.1093/carcin/bgy114.

PMID:
30165468
22.

Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E.

Coia H, Ma N, Hou Y, Dyba MD, Fu Y, Cruz MI, Benitez C, Graham GT, McCutcheon JN, Zheng YL, Sun B, Kallakury BV, Ma J, Fang HB, Berry DL, Muralidaran V, Chung FL.

Cancer Prev Res (Phila). 2018 Oct;11(10):665-676. doi: 10.1158/1940-6207.CAPR-18-0160. Epub 2018 Aug 21.

23.

Epstein-Barr Virus-Positive CD20- and CD45-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.

Starr A, Kwon DH, Kallakury B.

Int J Surg Pathol. 2019 Feb;27(1):98-101. doi: 10.1177/1066896918784669. Epub 2018 Jul 3.

PMID:
29968492
24.

Programmed Death Ligand 1: A Step Toward Immunoscore for Esophageal Cancer.

Hynes CF, Kwon DH, Vadlamudi C, Lofthus A, Iwamoto A, Chahine JJ, Desale S, Margolis M, Kallakury BV, Watson TJ, Haddad NG, Marshall MB.

Ann Thorac Surg. 2018 Oct;106(4):1002-1007. doi: 10.1016/j.athoracsur.2018.05.002. Epub 2018 May 30.

PMID:
29859152
25.

Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder.

Wang H, Wang Y, Kota KK, Sun B, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Sun SX, Chen X, Loffredo CA, Zheng YL.

Sci Rep. 2018 May 22;8(1):8183. doi: 10.1038/s41598-018-26488-0.

26.

Detection of a lipid peroxidation-induced DNA adduct across liver disease stages.

Coia H, Ma N, He AR, Kallakury B, Berry DL, Permaul E, Makambi KH, Fu Y, Chung FL.

Hepatobiliary Surg Nutr. 2018 Apr;7(2):85-97. doi: 10.21037/hbsn.2017.06.01.

27.

Rectal ulcer and pseudomalignant epithelial changes after prostate seed brachytherapy: A rare complication with a diagnostic pitfall.

Lee H, Sheuka N, El-Kadi O, Murray BP, Fisher HA, Kallakury BVS, Lee EC, Boguniewicz A, Jennings TA.

Ann Diagn Pathol. 2018 Jun;34:131-134. doi: 10.1016/j.anndiagpath.2018.03.011. Epub 2018 Apr 4.

PMID:
29661719
28.

LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.

Sehrawat A, Gao L, Wang Y, Bankhead A 3rd, McWeeney SK, King CJ, Schwartzman J, Urrutia J, Bisson WH, Coleman DJ, Joshi SK, Kim DH, Sampson DA, Weinmann S, Kallakury BVS, Berry DL, Haque R, Van Den Eeden SK, Sharma S, Bearss J, Beer TM, Thomas GV, Heiser LM, Alumkal JJ.

Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188. doi: 10.1073/pnas.1719168115. Epub 2018 Mar 26.

29.

Primary Langerhans Cell Histiocytosis of the Extrahepatic Bile Duct Occurring in an Adult Patient

Obiorah IE, Velasquez AH, Kallakury B, Özdemirli M.

Balkan Med J. 2018 Nov 15;35(6):437-439. doi: 10.4274/balkanmedj.2017.1730. Epub 2018 Mar 8.

30.

Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing.

Alamri AM, Liu X, Blancato JK, Haddad BR, Wang W, Zhong X, Choudhary S, Krawczyk E, Kallakury BV, Davidson BJ, Furth PA.

Dis Model Mech. 2018 Jan 29;11(1). pii: dmm031716. doi: 10.1242/dmm.031716.

31.

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.

Giaccone G, Kim C, Thompson J, McGuire C, Kallakury B, Chahine JJ, Manning M, Mogg R, Blumenschein WM, Tan MT, Subramaniam DS, Liu SV, Kaplan IM, McCutcheon JN.

Lancet Oncol. 2018 Mar;19(3):347-355. doi: 10.1016/S1470-2045(18)30062-7. Epub 2018 Jan 26.

PMID:
29395863
32.

Landscape of genome-wide age-related DNA methylation in breast tissue.

Song MA, Brasky TM, Weng DY, McElroy JP, Marian C, Higgins MJ, Ambrosone C, Spear SL, Llanos AA, Kallakury BVS, Freudenheim JL, Shields PG.

Oncotarget. 2017 Nov 29;8(70):114648-114662. doi: 10.18632/oncotarget.22754. eCollection 2017 Dec 29.

33.

The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ.

Ory V, Kietzman WB, Boeckelman J, Kallakury BV, Wellstein A, Furth PA, Riegel AT.

Breast Cancer Res Treat. 2018 May;169(1):47-57. doi: 10.1007/s10549-017-4649-y. Epub 2018 Jan 19.

34.

Sleep and Breast Cancer in the Western New York Exposures and Breast Cancer (WEB) Study.

Vaughn CB, Freudenheim JL, Nie J, Sucheston-Campbell L, Wactawski-Wende J, Marian C, Shields PG, Kallakury BV, Trevisan M, Ochs-Balcom HM.

J Clin Sleep Med. 2018 Jan 15;14(1):81-86. doi: 10.5664/jcsm.6886.

35.

Collaborative Multi-institutional Experience in Comparing PD-L1 Immunohistochemistry Assays: Concordance of SP142 and 22C3 Immunoreactivity.

Abdul Karim L, Kallakury BVS, Chahine JJ, Sheehan CE, Ross JS.

Appl Immunohistochem Mol Morphol. 2018 Feb;26(2):e22. doi: 10.1097/PAI.0000000000000609. No abstract available.

PMID:
29189261
36.

Combined Small Cell Carcinoma of the Lung: Is It a Single Entity?

Zhao X, McCutcheon JN, Kallakury B, Chahine JJ, Pratt D, Raffeld M, Chen Y, Wang C, Giaccone G.

J Thorac Oncol. 2018 Feb;13(2):237-245. doi: 10.1016/j.jtho.2017.10.010. Epub 2017 Oct 31.

37.

RE: Appendiceal Immunoglobulin G4-Related Disease Mimicking Appendiceal Tumor or Appendicitis: A Case Report.

Kwon DH, Kallakury BV.

Korean J Radiol. 2017 Nov-Dec;18(6):1012-1013. doi: 10.3348/kjr.2017.18.6.1012. Epub 2017 Sep 21. No abstract available.

38.

Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.

Mahajan AS, Sugita BM, Duttargi AN, Saenz F, Krawczyk E, McCutcheon JN, Fonseca AS, Kallakury B, Pohlmann P, Gusev Y, Cavalli LR.

PLoS One. 2017 Oct 19;12(10):e0186190. doi: 10.1371/journal.pone.0186190. eCollection 2017.

39.

Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder.

Wang H, Wang Y, Kota KK, Sun B, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Sun SX, Chen X, Loffredo CA, Zheng YL.

Sci Rep. 2017 Oct 18;7(1):13493. doi: 10.1038/s41598-017-13976-y. Erratum in: Sci Rep. 2018 May 22;8(1):8183.

40.

Increased Transgenerational Intestinal Tumorigenesis in Offspring of Ionizing Radiation Exposed Parent APC1638N/+ Mice.

Suman S, Kumar S, Moon BH, Fornace AJ Jr, Kallakury BVS, Datta K.

J Cancer. 2017 Jul 1;8(10):1769-1773. doi: 10.7150/jca.17803. eCollection 2017.

41.

An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.

Fu Y, Silverstein S, McCutcheon JN, Dyba M, Nath RG, Aggarwal M, Coia H, Bai A, Pan J, Jiang J, Kallakury B, Wang H, Zhang YW, Giaccone G, He AR, Chung FL.

Hepatology. 2018 Jan;67(1):159-170. doi: 10.1002/hep.29380. Epub 2017 Nov 13.

42.

Harmonization of PD-L1 Immunohistochemistry Assays for Lung Cancer: A Working Progress.

Abdul Karim L, Wang P, Chahine J, Kallakury B.

J Thorac Oncol. 2017 May;12(5):e45. doi: 10.1016/j.jtho.2016.12.022. No abstract available.

43.

Responsiveness of Brca1 and Trp53 Deficiency-Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus.

Alothman SJ, Wang W, Goerlitz DS, Islam M, Zhong X, Kishore A, Azhar RI, Kallakury BV, Furth PA.

Cancer Prev Res (Phila). 2017 Apr;10(4):244-254. doi: 10.1158/1940-6207.CAPR-16-0268. Epub 2017 Mar 10.

44.

Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.

Liu X, Krawczyk E, Suprynowicz FA, Palechor-Ceron N, Yuan H, Dakic A, Simic V, Zheng YL, Sripadhan P, Chen C, Lu J, Hou TW, Choudhury S, Kallakury B, Tang DG, Darling T, Thangapazham R, Timofeeva O, Dritschilo A, Randell SH, Albanese C, Agarwal S, Schlegel R.

Nat Protoc. 2017 Feb;12(2):439-451. doi: 10.1038/nprot.2016.174. Epub 2017 Jan 26.

45.

PD-L1 IHC assays in melanoma.

Abdul Karim L, Wang P, Chahine J, Kallakury B.

Histopathology. 2017 Jun;70(7):1177-1179. doi: 10.1111/his.13174. Epub 2017 Mar 20. No abstract available.

PMID:
28122123
46.

Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks.

Suresh M, Korolowicz KE, Balarezo M, Iyer RP, Padmanabhan S, Cleary D, Gimi R, Sheri A, Yon C, Kallakury BV, Tucker RD, Afdhal N, Menne S.

PLoS One. 2017 Jan 5;12(1):e0169631. doi: 10.1371/journal.pone.0169631. eCollection 2017.

47.

Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling.

Taslim C, Weng DY, Brasky TM, Dumitrescu RG, Huang K, Kallakury BV, Krishnan S, Llanos AA, Marian C, McElroy J, Schneider SS, Spear SL, Troester MA, Freudenheim JL, Geyer S, Shields PG.

Oncotarget. 2016 Dec 27;7(52):86457-86468. doi: 10.18632/oncotarget.13241.

48.

Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.

Sugita B, Gill M, Mahajan A, Duttargi A, Kirolikar S, Almeida R, Regis K, Oluwasanmi OL, Marchi F, Marian C, Makambi K, Kallakury B, Sheahan L, Cavalli IJ, Ribeiro EM, Madhavan S, Boca S, Gusev Y, Cavalli LR.

Oncotarget. 2016 Nov 29;7(48):79274-79291. doi: 10.18632/oncotarget.13024.

49.

Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B.

Korolowicz KE, Iyer RP, Czerwinski S, Suresh M, Yang J, Padmanabhan S, Sheri A, Pandey RK, Skell J, Marquis JK, Kallakury BV, Tucker RD, Menne S.

PLoS One. 2016 Aug 23;11(8):e0161313. doi: 10.1371/journal.pone.0161313. eCollection 2016.

50.

Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.

Jesudian A, Desale S, Julia J, Landry E, Maxwell C, Kallakury B, Laurin J, Shetty K.

J Clin Exp Hepatol. 2016 Jun;6(2):109-14. doi: 10.1016/j.jceh.2015.10.005. Epub 2015 Nov 12.

Supplemental Content

Loading ...
Support Center